Kenvue Inc. Common Stock vs Teradata Corporation Common Stock — how do they compare? Kenvue Inc. Common Stock trades at $18.13 (market cap $34.11B), while Teradata Corporation Common Stock trades at $29.6 (market cap $2.83B). The key difference: Kenvue Inc. Common Stock is far larger — about 12.1× Teradata Corporation Common Stock's market cap, and Kenvue Inc. Common Stock pays a 4.73% dividend while Teradata Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kenvue Inc. Common Stock for 1 Days and Teradata Corporation Common Stock for 0 Days on average.
| KVUE | TDC | |
|---|---|---|
Market Cap | $34.11B | $2.83B |
Volume | 27,388,811 | 1,343,944 |
Sector | Consumer Staples | Technology |
52-Week High | $19.83 | $37.88 |
52-Week Low | $14.11 | $20.71 |
Typical Hold Time | 1 Days | 0 Days |
Enterprise Value | $41.62B | $2.52B |
Dividend Yield | 4.73% | — |
Signals from Pluang's Aura AI — not financial advice
Kenvue (KVUE) trades at $17.76, down 0.39% on the day, with a bearish technical signal and neutral oscillators. The company reported revenue of $15.12B in 2025, with a net income margin of 10.76% and a P/E ratio of 20.89. Recent news highlights conditional EU approval for Kimberly-Clark's $40B acquisition of Kenvue, potentially impacting future operations and shareholder returns.
The outlook is mixed, with strong profitability and consistent dividend payments offering stability, but the pending acquisition introduces uncertainty. Risks include integration challenges and market volatility. Analyst consensus is a Hold with a $19.50 price target, suggesting limited near-term upside from current levels.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →Teradata Corporation develops a hybrid cloud analytics and data platform, including its Teradata Vantage and VantageCloud products, that helps enterprises manage and analyze data across cloud, on-premises, and hybrid environments. It serves industries including retail, financial services, healthcare, and manufacturing.
Read more on TDC →